Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arcus Biosciences, Inc. Director's Dealing 2018

Mar 19, 2018

31966_dirs_2018-03-19_16fc65bd-7df8-4e1e-8d23-fa906b1d7558.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2018-03-19

Reporting Person: COLUMN GROUP II, LP (10% Owner)
Reporting Person: Column Group II GP, LP (10% Owner)
Reporting Person: Ponoi Management, LLC (10% Owner)
Reporting Person: PONOI CAPITAL, LP (10% Owner)
Reporting Person: GOEDDEL DAVID V (10% Owner)
Reporting Person: Svennilson Peter (10% Owner)
Reporting Person: Kutzkey Tim (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-03-19 Common Stock C 1767676 Acquired 1767676 Direct
2018-03-19 Common Stock C 875087 Acquired 2642763 Direct
2018-03-19 Common Stock C 427660 Acquired 3070423 Direct
2018-03-19 Common Stock C 470427 Acquired 470427 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-03-19 Series A Preferred Stock $ C 1767676 Disposed Common Stock (1767676) Direct
2018-03-19 Series B Preferred Stock $ C 875087 Disposed Common Stock (2642763) Direct
2018-03-19 Series C Preferred Stock $ C 427660 Disposed Common Stock (3070423) Direct
2018-03-19 Series C Preferred Stock $ C 470427 Disposed Common Stock (470427) Direct

Footnotes

F1: Immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A, Series B and Series C preferred stock automatically converted into one share of common stock. The Series A, Series B and Series C preferred stock had no expiration date.

F2: The securities are directly held by The Column Group II, LP ("TCG II") and indirectly held by The Column Group II GP, LP ("TCG II GP") the general partner of TCG II. TCG II GP has voting and dispositive power with respect to these shares. The individual managing partners of TCG II GP are Peter Svennilson and David Goeddel, who may be deemed to have shared voting, investment and dispositive power with respect to these shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares

F3: The securities are directly held by Ponoi Capital, LP ("Ponoi LP") and indirectly held by Ponoi Management, LLC ("Ponoi LLC") the general partner of Ponoi LP. Ponoi LLC has voting and dispositive power with respect to these shares. The individual managing partners of Ponoi LLC are Peter Svennilson, David Goeddel and Tim Kutzkey, who may be deemed to have shared voting, investment and dispositive power with respect to these shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.